With SNP-based genome-wide association studies (GWAS) nearing signal saturation, exploring copy number variation (CNV) can offer new insights into the genetic architecture of complex traits. The authors review recent advances that enable large-scale CNV-based GWAS and their likely impact on downstream analyses, such as polygenic risk scoring and drug target identification.
- Laura Harris
- Ellen M. McDonagh
- Tomas Fitzgerald